Back to mobile site

Jefferies Assumes AcelRx Pharmaceuticals (ACRX) at Buy

July 14, 2017 6:38 AM EDT Send to a Friend
Jefferies assumes coverage on AcelRx Pharmaceuticals (NASDAQ: ACRX) with a Buy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login